Delivery Order SPE2DB22D1017-SPE2DB25FYRTH
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Isotretinoin 30 mg capsules (30-count) with a contract ceiling value of $1,645.60. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of ten. This competitively awarded, non-set-aside contract carries a ceiling value of $1,873.80 and features firm fixed-price pricing, with an ultimate completion date of September 9, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Isotretinoin 30 mg capsules in quantities of 10, with a contract ceiling value of $1,688.16. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure and is scheduled for ultimate completion by June 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at...
- The Defense Logistics Agency awarded a delivery order valued at $3,956.40 to AmerisourceBergen Drug Corp for 30-milligram Isotretinoin capsules (30-count packages) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price, non-set-aside contract represents a child award under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11.4K to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,584.30 to AmerisourceBergen Drug Corp for Isotretinoin 20 mg capsules (30-count packaging) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,105.68 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,119,316 units of Isotretinoin 40 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,085.34 by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of Isotretinoin 30 mg capsules (30-count packaging). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 27, 2025. The contract will be performed at the awardee's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,958.75 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count packaging) on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price, non-set-aside contract was awarded competitively and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $5,573.52 to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of 4,564,388,935 units of the pharmaceutical product ISOTRETINOIN 30 MG CAPSULE 30S, with a completion date of April 25, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRTHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units) with a ceiling value of $7,051.35. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 24, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company's DLA IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of diverse medical commodities—including specialty medications, brand-name and generic drugs, vaccines, and medical supplies—across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order falls within the company's established role as a critical vendor for federal pharmaceutical supply chain operations and reflects the DLA's reliance on AmerisourceBergen to fulfill routine medical supply requirements for defense and healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 9/23/25 |